The crosstalk between autophagy and ferroptosis in pulmonary fibrosis

Abstract

Pulmonary fibrosis (PF) is a progressive lung disorder characterized by excessive deposition of extracellular matrix (ECM) in the alveoli, with irreversible fibrotic remodeling and destruction of alveolar structures. Clinically, PF is manifested by progressive dyspnea and a decline in lung function. These manifestations contribute to a poor prognosis and significantly diminish the quality of life of affected individuals. Current therapeutic options for PF remain limited, highlighting the urgent need to elucidate its molecular mechanisms in order to develop novel treatment strategies. Recent studies have revealed that autophagy, a lysosome-dependent cellular degradation process, and ferroptosis, an iron-dependent form of regulated cell death, engage in intricate crosstalk that may regulate PF pathogenesis. Autophagy maintains cellular homeostasis by mediating lysosome-dependent degradation, whereas ferroptosis is characterized by iron-dependent lipid peroxidation. The interplay between autophagy and ferroptosis plays a pivotal role in modulating fibrosis progression. However, the mechanistic interactions between autophagy and ferroptosis in PF remain poorly understood, particularly regarding their bidirectional crosstalk and their unique role in PF progression. This review aims to systematically synthesize the current understanding of autophagy-ferroptosis interactions in PF, thereby identifying potential therapeutic strategies and drug targets for PF treatment.

Keywords

pulmonary fibrosis / autophagy / ferroptosis / pathogenic mechanism / treatment strategies

References

[1] Zhang X, Zhang X, Huang W, et al. The role of heat shock proteins in the regulation of fibrotic diseases[J]. Biomed Pharmacother, 2021, 135: 111067. doi: 10.1016/j.biopha.2020.111067

[2] Cheng D, Lian W, Jia X, et al. LGALS3 regulates endothelial-to-mesenchymal transition via PI3K/AKT signaling pathway in silica-induced pulmonary fibrosis[J]. Toxicology, 2024, 509: 153962. doi: 10.1016/j.tox.2024.153962

[3] Wang Y, Jiao L, Qiang C, et al. The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms[J]. Biomed Pharmacother, 2024, 171: 116116. doi: 10.1016/j.biopha.2023.116116

[4] Green FHY. Overview of pulmonary fibrosis[J]. Chest, 2002, 122(S6): 334S-339S. doi: 10.1378/chest.122.6_suppl.334s

[5] Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official ATS/ERS/JRS/ALAT clinical practice guideline[J]. Am J Respir Crit Care Med, 2022, 205(9): e18-e47. doi: 10.1164/rccm.202202-0399ST

[6] Chanda D, Otoupalova E, Smith SR, et al. Developmental pathways in the pathogenesis of lung fibrosis[J]. Mol Aspects Med, 2019, 65: 56-69. doi: 10.1016/j.mam.2018.08.004

[7] Wollin L, Distler JHW, Redente EF, et al. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases[J]. Eur Respir J, 2019, 54(3): 1900161. doi: 10.1183/13993003.00161-2019

[8] Jiang M, Bu W, Wang X, et al. Pulmonary fibrosis: From mechanisms to therapies[J]. J Transl Med, 2025, 23(1): 515. doi: 10.1186/s12967-025-06514-2

[9] Haspel JA, Choi AMK. Autophagy: A core cellular process with emerging links to pulmonary disease[J]. Am J Respir Crit Care Med, 2011, 184(11): 1237-1246. doi: 10.1164/rccm.201106-0966CI

[10] Yin J, Xu X, Guo Y, et al. Repair and regeneration: Ferroptosis in the process of remodeling and fibrosis in impaired organs[J]. Cell Death Discov, 2024, 10(1): 424. doi: 10.1038/s41420-024-02181-2

[11] Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis[J]. FEBS J, 2022, 289(22): 7038-7050. doi: 10.1111/febs.16059

[12] Fuhrmann DC, Brüne B. A graphical journey through iron metabolism, microRNAs, and hypoxia in ferroptosis[J]. Redox Biol, 2022, 54: 102365. doi: 10.1016/j.redox.2022.102365

[13] Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis[J]. Annu Rev Pathol: Mech Dis, 2022, 17(1): 515-546. doi: 10.1146/annurev-pathol-042320-030240

[14] Yamamoto H, Matsui T. Molecular mechanisms of macroautophagy, microautophagy, and chaperone-mediated autophagy[J]. J Nippon Med Sch, 2024, 91(1): 2-9. doi: 10.1272/jnms.JNMS.2024_91-102

[15] Wang Z, Liu J, Zhu Z, et al. Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: A mechanism review[J]. Biomed Pharmacother, 2021, 133: 110968. doi: 10.1016/j.biopha.2020.110968

[16] Liu S, Yao S, Yang H, et al. Autophagy: Regulator of cell death[J]. Cell Death Dis, 2023, 14(10): 648. doi: 10.1038/s41419-023-06154-8

[17] Din MAU, Lin Y, Wang N, et al. Ferroptosis and the ubiquitin-proteasome system: Exploring treatment targets in cancer[J]. Front Pharmacol, 2024, 15: 1383203. doi: 10.3389/fphar.2024.1383203

[18] Wang Y, Zhang Z, Sun W, et al. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets[J]. Biomed Pharmacother, 2022, 153: 113524. doi: 10.1016/j.biopha.2022.113524

[19] Shen J, San W, Zheng Y, et al. Different types of cell death in diabetic endothelial dysfunction[J]. Biomed Pharmacother, 2023, 168: 115802. doi: 10.1016/j.biopha.2023.115802

[20] Zhu P, Qian J, Xu Z, et al. Piperlonguminine and piperine analogues as TrxR inhibitors that promote ROS and autophagy and regulate p38 and Akt/mTOR signaling[J]. J Nat Prod, 2020, 83(10): 3041-3049. doi: 10.1021/acs.jnatprod.0c00599

[21] Ballesteros-Álvarez J, Andersen JK. mTORC2: The other mTOR in autophagy regulation[J]. Aging Cell, 2021, 20(8): e13431. doi: 10.1111/acel.13431

[22] Lei G, Zhuang L, Gan BY. mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential[J]. BioEssays, 2021, 43(8): 2100093. doi: 10.1002/bies.202100093

[23] Larrue C, Mouche S, Angelino P, et al. Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models[J]. Sci Transl Med, 2024, 16(757): eadk1731. doi: 10.1126/scitranslmed.adk1731

[24] Mao Z, Zhong K, Liu X, et al. Ferroptosis contributes to cyclophosphamide-induced hemorrhagic cystitis[J]. Chem Biol Interact, 2023, 384: 110701. doi: 10.1016/j.cbi.2023.110701

[25] He J, Li M, Bao J, et al. β-Elemene promotes ferroptosis and reverses radioresistance in gastric cancer by inhibiting the OTUB1-GPX4 interaction[J]. Front Pharmacol, 2024, 15: 1469180. doi: 10.3389/fphar.2024.1469180

[26] Lee H, Fei Q, Streicher A, et al. mTORC1 is a mechanosensor that regulates surfactant function and lung compliance during ventilator-induced lung injury[J]. JCI Insight, 2021, 6(14): e137708. doi: 10.1172/jci.insight.137708

[27] Ali MF, Egan AM, Shaughnessy GF, et al. Antifibrotics modify B-cell-induced fibroblast migration and activation in patients with idiopathic pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2021, 64(6): 722-733. doi: 10.1165/rcmb.2020-0387OC

[28] Li Y, Chen Y. AMPK and autophagy[J]. Adv Exp Med Biol, 2019, 1206: 85-108. doi: 10.1007/978-981-15-0602-4_4

[29] Wang S, Tao J, Chen H, et al. Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy[J]. Acta Pharm Sin B, 2021, 11(11): 3508-3526. doi: 10.1016/j.apsb.2021.07.006

[30] Herzig S, Shaw RJ. AMPK: Guardian of metabolism and mitochondrial homeostasis[J]. Nat Rev Mol Cell Biol, 2018, 19(2): 121-135. doi: 10.1038/nrm.2017.95

[31] Xu A, Yuan K, Xue S, et al. Laminin-dystroglycan mediated ferroptosis in hemorrhagic shock and reperfusion induced-cognitive impairment through AMPK/Nrf2[J]. Free Radic Biol Med, 2025, 230: 1-16. doi: 10.1016/j.freeradbiomed.2025.01.046

[32] Rojo de la Vega M, Chapman E, Zhang D. NRF2 and the hallmarks of cancer[J]. Cancer Cell, 2018, 34(1): 21-43. doi: 10.1016/j.ccell.2018.03.022

[33] Cheng D, Xu Q, Wang Y, et al. Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling[J]. J Transl Med, 2021, 19(1): 349. doi: 10.1186/s12967-021-03036-5

[34] Li N, Chang M, Zhou Q, et al. Activation of AMPK signalling by Metformin: Implication an important molecular mechanism for protecting against mice silicosis via inhibited endothelial cell-to-mesenchymal transition by regulating oxidative stress and apoptosis[J]. Int Immunopharmacol, 2023, 120: 110321. doi: 10.1016/j.intimp.2023.110321

[35] Shi L, Han Q, Hong Y, et al. Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis[J]. Stem Cell Res Ther, 2021, 12(1): 147. doi: 10.1186/s13287-021-02215-x

[36] Zhu Z, Hu R, Li J, et al. Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis[J]. Int Immunopharmacol, 2021, 96: 107660. doi: 10.1016/j.intimp.2021.107660

[37] Stępkowski TM, Kruszewski MK. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis[J]. Free Radic Biol Med, 2011, 50(9): 1186-1195. doi: 10.1016/j.freeradbiomed.2011.01.033

[38] Elander PH, Holla S, Sabljić I, et al. Interactome of Arabidopsis ATG5 suggests functions beyond autophagy[J]. Int J Mol Sci, 2023, 24(15): 12300. doi: 10.3390/ijms241512300

[39] Hu Q, Zuo T, Deng L, et al. β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats[J]. Phytomedicine, 2022, 102: 154112. doi: 10.1016/j.phymed.2022.154112

[40] Shan C, Wang Y, Wang Y. The crosstalk between autophagy and Nrf2 signaling in cancer: From biology to clinical applications[J]. Int J Biol Sci, 2024, 20(15): 6181-6206. doi: 10.7150/ijbs.103187

[41] Zhang J, Zhang L, Yao G, et al. NRF2 is essential for iron-overload stimulated osteoclast differentiation through regulation of redox and iron homeostasis[J]. Cell Biol Toxicol, 2023, 39(6): 3305-3321. doi: 10.1007/s10565-023-09834-5

[42] Wei J, Zhu H, Komura K, et al. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses[J]. Ann Rheum Dis, 2014, 73(2): 446-454. doi: 10.1136/annrheumdis-2012-202716

[43] Sussan TE, Gajghate S, Chatterjee S, et al. Nrf2 reduces allergic asthma in mice through enhanced airway epithelial cytoprotective function[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 309(1): L27-L36. doi: 10.1152/ajplung.00398.2014

[44] Guan H, Sun J, Liang X, et al. Protective role of cytochrome C oxidase 5A (COX5A) against mitochondrial disorder and oxidative stress in VSMC phenotypic modulation and neointima formation[J]. Curr Vasc Pharmacol, 2023, 21(2): 128-142. doi: 10.2174/1570161121666230315142507

[45] Zhang R, Zhu Z, Ma Y, et al. Rhizoma Alismatis Decoction improved mitochondrial dysfunction to alleviate SASP by enhancing autophagy flux and apoptosis in hyperlipidemia acute pancreatitis[J]. Phytomedicine, 2024, 129: 155629. doi: 10.1016/j.phymed.2024.155629

[46] Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances[J]. Signal Transduct Target Ther, 2025, 10(1): 190. doi: 10.1038/s41392-025-02253-4

[47] Li J, Jia Y, Ding Y, et al. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks[J]. Int J Biol Sci, 2023, 19(9): 2756-2771. doi: 10.7150/ijbs.83348

[48] Bi Y, Liu S, Qin X, et al. FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner[J]. J Adv Res, 2024, 55: 45-60. doi: 10.1016/j.jare.2023.02.012

[49] Punziano C, Trombetti S, Cesaro E, et al. Antioxidant systems as modulators of ferroptosis: Focus on transcription factors[J]. Antioxidants (Basel), 2024, 13(3): 298. doi: 10.3390/antiox13030298

[50] Xu L, Liu Y, Chen X, et al. Ferroptosis in life: To be or not to be[J]. Biomed Pharmacother, 2023, 159: 114241. doi: 10.1016/j.biopha.2023.114241

[51] Wei Y, Chen T, Zhang D, et al. Microplastics exacerbate ferroptosis via mitochondrial reactive oxygen species-mediated autophagy in chronic obstructive pulmonary disease[J]. Autophagy, 2025, 21(8): 1717-1743. doi: 10.1080/15548627.2025.2481126

[52] Li T, Sun M, Sun Q, et al. PM_2.5-induced iron homeostasis imbalance triggers cardiac hypertrophy through ferroptosis in a selective autophagy crosstalk manner[J]. Redox Biol, 2024, 72: 103158. doi: 10.1016/j.redox.2024.103158

[53] Li C, Zhang Y, Liu J, et al. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death[J]. Autophagy, 2021, 17(4): 948-960. doi: 10.1080/15548627.2020.1739447

[54] Chen C, Dai G, Fan M, et al. Mitochondria-associated endoplasmic reticulum membranes and myocardial ischemia: From molecular mechanisms to therapeutic strategies[J]. J Transl Med, 2025, 23(1): 277. doi: 10.1186/s12967-025-06262-3

[55] Yuan J, Yao C, Tang J, et al. Enhanced GRP78 protein expression via the IRE1α/ASK1/p38 MAPK pathway during As₂O₃-induced endoplasmic reticulum stress in BEAS-2B cells[J]. Toxicology, 2021, 462: 152962. doi: 10.1016/j.tox.2021.152962

[56] Ji X, Chen Z, Lin W, et al. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades[J]. J Ethnopharmacol, 2024, 328: 118139. doi: 10.1016/j.jep.2024.118139

[57] Liu H, Lai W, Nie H, et al. PM_2.5 triggers autophagic degradation of Caveolin-1 via endoplasmic reticulum stress (ERS) to enhance the TGF-β1/Smad3 axis promoting pulmonary fibrosis[J]. Environ Int, 2023, 181: 108290. doi: 10.1016/j.envint.2023.108290

[58] Liao H, Liu S, Ma Q, et al. Endoplasmic reticulum stress induced autophagy in cancer and its potential interactions with apoptosis and ferroptosis[J]. Biochim Biophys Acta Mol Cell Res, 2025, 1872(1): 119869. doi: 10.1016/j.bbamcr.2024.119869

[59] Yao D, Chen E, Li Y, et al. The role of endoplasmic reticulum stress, mitochondrial dysfunction and their crosstalk in intervertebral disc degeneration[J]. Cell Signal, 2024, 114: 110986. doi: 10.1016/j.cellsig.2023.110986

[60] Zhou R, Wei K, Li X, et al. Mechanisms of ferroptosis and the relationship between ferroptosis and ER stress after JEV and HSV infection[J]. Front Microbiol, 2024, 15: 1415417. doi: 10.3389/fmicb.2024.1415417

[61] Dong Z, Li T, Wang C, et al. Sestrin2 regulates endoplasmic reticulum stress-dependent ferroptosis to engage pulmonary fibrosis by nuclear factor erythroid 2-related factor 2/activating transcription factor 4 (NRF2/ATF4)[J]. J Immunol Res, 2023, 2023(1): 9439536. doi: 10.1155/2023/9439536

[62] Wang Y, Wei J, Deng H, et al. The role of Nrf2 in pulmonary fibrosis: Molecular mechanisms and treatment approaches[J]. Antioxidants (Basel), 2022, 11(9): 1685. doi: 10.3390/antiox11091685

[63] Tai W, Deng S, Wu W, et al. Rapamycin attenuates the paraquat-induced pulmonary fibrosis through activating Nrf2 pathway[J]. J Cell Physiol, 2020, 235(2): 1759-1768. doi: 10.1002/jcp.29094

[64] Feng F, Cheng P, Xu S, et al. Tanshinone ⅡA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling[J]. Chem Biol Interact, 2020, 319: 109024. doi: 10.1016/j.cbi.2020.109024

[65] Xin X, Yao D, Zhang K, et al. Protective effects of Rosavin on bleomycin-induced pulmonary fibrosis via suppressing fibrotic and inflammatory signaling pathways in mice[J]. Biomed Pharmacother, 2019, 115: 108870. doi: 10.1016/j.biopha.2019.108870

[66] Wu M, Li H, Zhai R, et al. Tanshinone ⅡA positively regulates the Keap1-Nrf2 system to alleviate pulmonary fibrosis via the sestrin2-sqstm1 signaling axis-mediated autophagy[J]. Phytomedicine, 2024, 129: 155620. doi: 10.1016/j.phymed.2024.155620

[67] Wang Y, Zhang C, Ma Y, et al. Therapeutic effects of C-28 methyl ester of 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice[J]. Drug Des Devel Ther, 2015, 9: 3163-3178. doi: 10.2147/DDDT.S80958

[68] Nie Z, Wu J, Xie J, et al. Sinomenine ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the differentiation of fibroblast into myofibroblast[J]. Heliyon, 2024, 10(13): e33314. doi: 10.1016/j.heliyon.2024.e33314

[69] Vishnupriya S, Priya Dharshini LC, Sakthivel KM, et al. Autophagy markers as mediators of lung injury-implication for therapeutic intervention[J]. Life Sci, 2020, 260: 118308. doi: 10.1016/j.lfs.2020.118308

[70] Zeng Q, Zhou T, Zhao F, et al. p62-Nrf2 regulatory loop mediates the anti-pulmonary fibrosis effect of bergenin[J]. Antioxidants (Basel), 2022, 11(2): 307. doi: 10.3390/antiox11020307

[71] Zeng Q, Wen B, Liu X, et al. NBR1-p62-Nrf2 mediates the anti-pulmonary fibrosis effects of protodioscin[J]. Chin Med, 2024, 19(1): 60. doi: 10.1186/s13020-024-00930-0

[72] Gu X, Han Y, Yang C, et al. Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1[J]. Pharmacol Res, 2021, 173: 105844. doi: 10.1016/j.phrs.2021.105844

[73] Álvarez RM, García AB, Riesco-Fagundo C, et al. Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors[J]. Eur J Med Chem, 2021, 211: 113109. doi: 10.1016/j.ejmech.2020.113109

[74] Lamming DW, Ye L, Sabatini DM, et al. Rapalogs and mTOR inhibitors as anti-aging therapeutics[J]. J Clin Invest, 2013, 123(3): 980-989. doi: 10.1172/JCI64099

[75] Subbiah V, Cascone T, Hess KR, et al. Multi-kinase RET inhibitor vandetanib combined with mTOR inhibitor everolimus in patients with RET rearranged non-small cell lung cancer[J]. J Clin Oncol, 2018, 36(S15): 9035. doi: 10.1200/JCO.2018.36.15_suppl.9035

[76] Tsubouchi K, Araya J, Yoshida M, et al. Involvement of GPx4-regulated lipid peroxidation in idiopathic pulmonary fibrosis pathogenesis[J]. J Immunol, 2019, 203(8): 2076-2087. doi: 10.4049/jimmunol.1801232

[77] Gaschler MM, Andia AA, Liu H, et al. FINO₂ initiates ferroptosis through GPX4 inactivation and iron oxidation[J]. Nat Chem Biol, 2018, 14(5): 507-515. doi: 10.1038/s41589-018-0031-6

[78] Artusi I, Rubin M, Cravin G, et al. Ferroptosis in human diseases: Fundamental roles and emerging therapeutic perspectives[J]. Front Pharmacol, 2025, 14(12): 1411. doi: 10.3390/antiox14121411

[79] Liu Y, Tang A, Liu M, et al. Tuberostemonine may enhance the function of the SLC7A11/glutamate antiporter to restrain the ferroptosis to alleviate pulmonary fibrosis[J]. J Ethnopharmacol, 2024, 318( Pt B): 116983.

[80] Ritzenthaler JD, Torres-Gonzalez E, Zheng Y, et al. The profibrotic and senescence phenotype of old lung fibroblasts is reversed or ameliorated by genetic and pharmacological manipulation of Slc7a11 expression[J]. Am J Physiol Lung Cell Mol Physiol, 2022, 322(3): L449-L461. doi: 10.1152/ajplung.00593.2020

[81] Ma J, Wang J, Ma C, et al. Wnt5a/Ca²⁺ signaling regulates silica-induced ferroptosis in mouse macrophages by altering ER stress-mediated redox balance[J]. Toxicology, 2023, 490: 153514. doi: 10.1016/j.tox.2023.153514

[82] Chen Y, Zhang X, Bai J, et al. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: Potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation[J]. Cell Death Dis, 2013, 4(6): e665. doi: 10.1038/cddis.2013.154

[83] Yang G, Yang Y, Liu Y, et al. Regulation of alveolar macrophage death in pulmonary fibrosis: A review[J]. Apoptosis, 2023, 28(11-12): 1505-1519. doi: 10.1007/s10495-023-01888-4

[84] Antar SA, Ashour NA, Marawan ME, et al. Fibrosis: Types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation[J]. Int J Mol Sci, 2023, 24(4): 4004. doi: 10.3390/ijms24044004

[85] Schafer MJ, White TA, Iijima K, et al. Cellular senescence mediates fibrotic pulmonary disease[J]. Nat Commun, 2017, 8: 14532. doi: 10.1038/ncomms14532

[86] Patel AS, Lin L, Geyer A, et al. Autophagy in idiopathic pulmonary fibrosis[J]. PLoS One, 2012, 7(7): e41394. doi: 10.1371/journal.pone.0041394

[87] Li S, Liu G, Gu M, et al. A novel therapeutic approach for IPF: Based on the "Autophagy-Apoptosis" balance regulation of Zukamu Granules in alveolar macrophages[J]. J Ethnopharmacol, 2022, 297: 115568. doi: 10.1016/j.jep.2022.115568

[88] Wang J, Li K, Hao D, et al. Pulmonary fibrosis: Pathogenesis and therapeutic strategies[J]. MedComm (2020), 2024, 5(10): e744. doi: 10.1002/mco2.744

[89] Zhou B, Liu J, Kang R, et al. Ferroptosis is a type of autophagy-dependent cell death[J]. Semin Cancer Biol, 2020, 66: 89-100. doi: 10.1016/j.semcancer.2019.03.002

[90] Yu Q, Tang X. Irreversibility of pulmonary fibrosis[J]. Aging Dis, 2022, 13(1): 73-86. doi: 10.14336/AD.2021.0730

[91] Migneault F, Hébert MJ. Autophagy, tissue repair, and fibrosis: A delicate balance[J]. Matrix Biol, 2021, 100-101: 182-196. doi: 10.1016/j.matbio.2021.01.003

[92] Di Gregorio J, Robuffo I, Spalletta S, et al. The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders[J]. Front Cell Dev Biol, 2020, 8: 607483. doi: 10.3389/fcell.2020.607483

[93] Roach KM, Sutcliffe A, Matthews L, et al. A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis[J]. Sci Rep, 2018, 8(1): 342. doi: 10.1038/s41598-017-18555-9

[94] Ren T, Shi J, Zhuang L, et al. ACSL4 drives C5a/C5aR1-calcium-induced fibroblast-to-myofibroblast transition in a bleomycin-induced mouse model of pulmonary fibrosis[J]. Biomolecules, 2025, 15(8): 1106. doi: 10.3390/biom15081106

[95] Prasad C, Hahn K, Duraisamy SK, et al. Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts[J]. Biochem Biophys Res Commun, 2023, 669: 120-127. doi: 10.1016/j.bbrc.2023.05.092

[96] Larson-Casey JL, Deshane JS, Ryan AJ, et al. Macrophage Akt1 kinase-mediated mitophagy modulates apoptosis resistance and pulmonary fibrosis[J]. Immunity, 2016, 44(3): 582-596. doi: 10.1016/j.immuni.2016.01.001

[97] Wu W, Jia H, Chen S, et al. Inhibition of OGG1 ameliorates pulmonary fibrosis via preventing M2 macrophage polarization and activating PINK1-mediated mitophagy[J]. Mol Med, 2024, 30(1): 72. doi: 10.1186/s10020-024-00843-6

[98] Huang G, Xu X, Ju C, et al. Identification and validation of autophagy-related gene expression for predicting prognosis in patients with idiopathic pulmonary fibrosis[J]. Front Immunol, 2022, 13: 997138. doi: 10.3389/fimmu.2022.997138

[99] Sharma P, Alizadeh J, Juarez M, et al. Autophagy, apoptosis, the unfolded protein response, and lung function in idiopathic pulmonary fibrosis[J]. Cells, 2021, 10(7): 1642. doi: 10.3390/cells10071642

[100] Fujii J, Imai H. Oxidative metabolism as a cause of lipid peroxidation in the execution of ferroptosis[J]. Int J Mol Sci, 2024, 25(14): 7544. doi: 10.3390/ijms25147544

[101] Ali MK, Kim RY, Brown AC, et al. Critical role for iron accumulation in the pathogenesis of fibrotic lung disease[J]. J Pathol, 2020, 251(1): 49-62. doi: 10.1002/path.5401

[102] Cheng H, Feng D, Li X, et al. Iron deposition-induced ferroptosis in alveolar type Ⅱ cells promotes the development of pulmonary fibrosis[J]. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(12): 166204. doi: 10.1016/j.bbadis.2021.166204

[103] Sun Y, Ren Y, Song L, et al. Targeting iron-metabolism: A potential therapeutic strategy for pulmonary fibrosis[J]. Biomed Pharmacother, 2024, 172: 116270. doi: 10.1016/j.biopha.2024.116270

[104] Zhang X, Liu Z, Wang M, et al. Mechanisms and regulations of ferroptosis[J]. Front Immunol, 2023, 14: 1269451. doi: 10.3389/fimmu.2023.1269451

[105] Li Z, Zhu Z, Liu Y, et al. Function and regulation of GPX4 in the development and progression of fibrotic disease[J]. J Cell Physiol, 2022, 237(7): 2808-2824. doi: 10.1002/jcp.30780

[106] Li S, Zhang H, Chang J, et al. Iron overload and mitochondrial dysfunction orchestrate pulmonary fibrosis[J]. Eur J Pharmacol, 2021, 912: 174613. doi: 10.1016/j.ejphar.2021.174613

[107] Doherty J, Baehrecke EH. Life, death and autophagy[J]. Nat Cell Biol, 2018, 20(10): 1110-1117. doi: 10.1038/s41556-018-0201-5

[108] Ma W, Li M, Ma H, et al. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways[J]. Life Sci, 2020, 241: 117139. doi: 10.1016/j.lfs.2019.117139

[109] Walters DM, Cho HY, Kleeberger SR. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: A potential role for Nrf2[J]. Antioxid Redox Signal, 2008, 10(2): 321-332. doi: 10.1089/ars.2007.1901

[110] Paul VD, Lill R. Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability[J]. Biochim Biophys Acta, 2015, 1853(6): 1528-1539. doi: 10.1016/j.bbamcr.2014.12.018

[111] Deng C, Lu C, Wang K, et al. Celecoxib ameliorates diabetic sarcopenia by inhibiting inflammation, stress response, mitochondrial dysfunction, and subsequent activation of the protein degradation systems[J]. Front Pharmacol, 2024, 15: 1344276. doi: 10.3389/fphar.2024.1344276

[112] Wu X, Jiang Y, Li R, et al. Ficolin B secreted by alveolar macrophage exosomes exacerbates bleomycin-induced lung injury via ferroptosis through the cGAS-STING signaling pathway[J]. Cell Death Dis, 2023, 14(8): 577. doi: 10.1038/s41419-023-06104-4

[113] Li X, Tan J, Xiong W, et al. Silica-induced ferroptosis activates retinoic acid signaling in dendritic cells to drive inflammation and fibrosis in silicosis[J]. Int Immunopharmacol, 2025, 149: 114244. doi: 10.1016/j.intimp.2025.114244

[114] Yue M, Luan R, Ding D, et al. Identification and validation of biomarkers related to ferroptosis in idiopathic pulmonary fibrosis[J]. Sci Rep, 2025, 15(1): 8622. doi: 10.1038/s41598-025-93217-9

[115] Li M, Wang K, Zhang Y, et al. Ferroptosis-related genes in bronchoalveolar lavage fluid serves as prognostic biomarkers for idiopathic pulmonary fibrosis[J]. Front Med (Lausanne), 2021, 8: 693959. doi: 10.3389/fmed.2021.693959

[116] Santana-Codina N, Mancias JD. The role of NCOA4-mediated ferritinophagy in health and disease[J]. Pharmaceuticals (Basel), 2018, 11(4): 114. doi: 10.3390/ph11040114

[117] Zeitler L, Fiore A, Meyer C, et al. Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism[J]. Elife, 2021, 10: e64806. doi: 10.7554/eLife.64806

[118] Redza-Dutordoir M, Averill-Bates DA. Interactions between reactive oxygen species and autophagy: Special issue: Death mechanisms in cellular homeostasis[J]. Biochim Biophys Acta Mol Cell Res, 2021, 1868(8): 119041. doi: 10.1016/j.bbamcr.2021.119041

[119] Fan Z, Cai L, Wang S, et al. Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis[J]. Front Pharmacol, 2021, 12: 628988. doi: 10.3389/fphar.2021.628988

[120] Jiang H, Zhang X, Yang W, et al. Ferrostatin-1 ameliorates liver dysfunction via reducing iron in thioacetamide-induced acute liver injury in mice[J]. Front Pharmacol, 2022, 13: 869794. doi: 10.3389/fphar.2022.869794

[121] Sottile R, Federico G, Garofalo C, et al. Iron and ferritin modulate MHC class I expression and NK cell recognition[J]. Front Immunol, 2019, 10: 224. doi: 10.3389/fimmu.2019.00224

[122] Zhang M, Tong Z, Wang Y, et al. Relationship between ferroptosis and mitophagy in renal fibrosis: A systematic review[J]. J Drug Target, 2023, 31(8): 858-866. doi: 10.1080/1061186X.2023.2250574

[123] Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation[J]. Cell Death Dis, 2019, 10(11): 822. doi: 10.1038/s41419-019-2064-5

[124] Liang N, Song W, Li J. BPA promotes lung fibrosis in mice by regulating autophagy-dependent ferroptosis in alveolar epithelial cells[J]. Ecotoxicol Environ Saf, 2024, 278: 116412. doi: 10.1016/j.ecoenv.2024.116412

[125] El-Horany HE, Atef MM, Abdel Ghafar MT, et al. Empagliflozin ameliorates bleomycin-induced pulmonary fibrosis in rats by modulating Sesn2/AMPK/Nrf2 signaling and targeting ferroptosis and autophagy[J]. Int J Mol Sci, 2023, 24(11): 9481. doi: 10.3390/ijms24119481

[126] Pei Z, Qin Y, Fu X, et al. Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model[J]. Redox Biol, 2022, 57: 102509. doi: 10.1016/j.redox.2022.102509

[127] Yan J, Wang S, Su Q, et al. Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile[J]. Nat Commun, 2025, 16(1): 3748. doi: 10.1038/s41467-025-59093-7

[128] Tevlin R, Longaker MT, Wan D. Deferoxamine to minimize fibrosis during radiation therapy[J]. Adv Wound Care (New Rochelle), 2022, 11(10): 548-559. doi: 10.1089/wound.2021.0021

[129] Yang L, Li X, Wang Y. Ferrostatin-1 inhibits fibroblast fibrosis in keloid by inhibiting ferroptosis[J]. PeerJ, 2024, 12: e17551. doi: 10.7717/peerj.17551

[130] Zilka O, Shah R, Li B, et al. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death[J]. ACS Cent Sci, 2017, 3(3): 232-243. doi: 10.1021/acscentsci.7b00028

[131] Miotto G, Rossetto M, Di Paolo ML, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1[J]. Redox Biol, 2020, 28: 101328. doi: 10.1016/j.redox.2019.101328

[132] Zhang W, Sun Z, Cheng W, et al. Impaired GPX4 activity elicits ferroptosis in alveolar type Ⅱ cells promoting PHMG-induced pulmonary fibrosis development[J]. Ecotoxicol Environ Saf, 2024, 281: 116680. doi: 10.1016/j.ecoenv.2024.116680

[133] Tao N, Li K, Liu J, et al. Liproxstatin-1 alleviates bleomycin-induced alveolar epithelial cells injury and mice pulmonary fibrosis via attenuating inflammation, reshaping redox equilibrium, and suppressing ROS/p53/α-SMA pathway[J]. Biochem Biophys Res Commun, 2021, 551: 133-139. doi: 10.1016/j.bbrc.2021.02.127

[134] Pan L, Cheng Y, Yang W, et al. Nintedanib ameliorates bleomycin-induced pulmonary fibrosis, inflammation, apoptosis, and oxidative stress by modulating PI3K/Akt/mTOR pathway in mice[J]. Inflammation, 2023, 46(4): 1531-1542. doi: 10.1007/s10753-023-01825-2

[135] Amati F, Stainer A, Polelli V, et al. Efficacy of pirfenidone and nintedanib in interstitial lung diseases other than idiopathic pulmonary fibrosis: A systematic review[J]. Int J Mol Sci, 2023, 24(9): 7849. doi: 10.3390/ijms24097849

[136] Lv Q, Wang J, Xu C, et al. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways[J]. Mol Med, 2020, 26(1): 49. doi: 10.1186/s10020-020-00173-3

[137] Guo J, Yang Z, Jia Q, et al. Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis model[J]. Toxicol Lett, 2019, 300: 59-66. doi: 10.1016/j.toxlet.2018.10.019

[138] Rangarajan S, Bone N, Zmijewska A, et al. Metformin reverses established lung fibrosis in a bleomycin model[J]. Nat Med, 2018, 24(8): 1121-1127. doi: 10.1038/s41591-018-0087-6

[139] Kheirollahi V, Wasnick RM, Biasin V, et al. Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis[J]. Nat Commun, 2019, 10(1): 2987. doi: 10.1038/s41467-019-10839-0

[140] Lawrence J, Nho R. The role of the mammalian target of rapamycin (mTOR) in pulmonary fibrosis[J]. Int J Mol Sci, 2018, 19(3): 778. doi: 10.3390/ijms19030778

[141] Gui Y, Wang L, Tian X, et al. mTOR overactivation and compromised autophagy in the pathogenesis of pulmonary fibrosis[J]. PLoS One, 2015, 10(9): e0138625. doi: 10.1371/journal.pone.0138625

[142] Chitra P, Saiprasad G, Manikandan R, et al. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: A biphasic experimental study[J]. Toxicol Lett, 2013, 219(2): 178-193. doi: 10.1016/j.toxlet.2013.03.009

[143] Zhang L, Chen J, Huang X, et al. Berberine ameliorates pulmonary fibrosis by inactivating the thrombospondin 2/smad homolog 2/3 pathway[J]. Chem Biol Drug Des, 2025, 105(4): e70111. doi: 10.1111/cbdd.70111

[144] Cheng D, Lian W, Wang T, et al. The interplay of Cxcl10⁺/Mmp14⁺ monocytes and Ccl3⁺ neutrophils proactively mediates silica-induced pulmonary fibrosis[J]. J Hazard Mater, 2024, 467: 133713. doi: 10.1016/j.jhazmat.2024.133713

[145] Adams TS, Schupp JC, Poli S, et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis[J]. Sci Adv, 2020, 6(28): eaba1983. doi: 10.1126/sciadv.aba1983

[146] Vannan A, Lyu R, Williams AL, et al. Spatial transcriptomics identifies molecular niche dysregulation associated with distal lung remodeling in pulmonary fibrosis[J]. Nat Genet, 2025, 57(3): 647-658. doi: 10.1038/s41588-025-02080-x